- Home
- CUE vs JZXN Comparison
CUE vs JZXN Comparison
Compare CUE & JZXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- JZXN
- Stock Information
- Founded
- CUE 2014
- JZXN 2019
- Country
- CUE United States
- JZXN China
- Employees
- CUE N/A
- JZXN N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- JZXN Retail-Auto Dealers and Gas Stations
- Sector
- CUE Health Care
- JZXN Consumer Discretionary
- Exchange
- CUE Nasdaq
- JZXN Nasdaq
- Market Cap
- CUE 59.5M
- JZXN 51.8M
- IPO Year
- CUE 2018
- JZXN 2021
- Fundamental
- Price
- CUE $0.72
- JZXN $1.00
- Analyst Decision
- CUE Strong Buy
- JZXN
- Analyst Count
- CUE 2
- JZXN 0
- Target Price
- CUE $3.00
- JZXN N/A
- AVG Volume (30 Days)
- CUE 132.0K
- JZXN 248.5K
- Earning Date
- CUE 11-13-2025
- JZXN 03-05-2026
- Dividend Yield
- CUE N/A
- JZXN N/A
- EPS Growth
- CUE N/A
- JZXN N/A
- EPS
- CUE N/A
- JZXN N/A
- Revenue
- CUE $8,286,000.00
- JZXN $97,465.00
- Revenue This Year
- CUE N/A
- JZXN N/A
- Revenue Next Year
- CUE $13.27
- JZXN N/A
- P/E Ratio
- CUE N/A
- JZXN N/A
- Revenue Growth
- CUE N/A
- JZXN N/A
- 52 Week Low
- CUE $0.45
- JZXN $0.78
- 52 Week High
- CUE $1.99
- JZXN $7.82
- Technical
- Relative Strength Index (RSI)
- CUE 34.73
- JZXN 54.31
- Support Level
- CUE $0.77
- JZXN $0.95
- Resistance Level
- CUE $0.78
- JZXN $1.11
- Average True Range (ATR)
- CUE 0.03
- JZXN 0.07
- MACD
- CUE -0.01
- JZXN 0.03
- Stochastic Oscillator
- CUE 9.53
- JZXN 64.71
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About JZXN Jiuzi Holdings Inc.
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its operating segments are propretaey product; and resale of sourced Equipment and accessories from third party products. The company generates a majority of its revenue from the propretaey product segment. Geographically, the firm operates in China.